2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$44.48$0.00 (0.00%)
Price as of Jun 23, 2026 5:39 PM EDT- $2.6BMarket Cap
- 39.04%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$44.48$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 626.5M -5.33% | 661.8M -0.81% | 667.2M +15.09% | 579.8M +11.41% | |
Cost of Revenue | 74.6M -4.29% | 77.9M -10.68% | 87.2M +16.20% | 75.1M +43.09% | |
Gross Profit | 552.0M -5.47% | 583.9M +0.67% | 580.0M +14.92% | 504.7M +7.86% | |
Sales and Marketing Expense | 485.6M +50.99% | 321.6M -14.75% | 377.2M +23.78% | 304.8M +51.87% | |
Research and Development Expense | -106.2M -2.35% | -108.8M +45.93% | -74.6M -17.59% | -90.5M +19.10% | |
Depreciation and Amortization Expense | 91.6M +13.86% | 80.4M -6.00% | 85.5M +162.44% | 32.6M +79.68% | |
Total Operating Expenses | 781.2M +34.66% | 580.2M -6.60% | 621.1M +25.80% | 493.7M +42.41% | |
Operating Profit | -62.3M -176.27% | 81.7M +77.06% | 46.1M -46.39% | 86.0M -50.47% | |
Interest Income | N/A N/A | N/A N/A | 21.7M +105.21% | 10.6M -43.49% | |
Interest Expense | 0 N/A | 0 +100.00% | -2.4M -87.73% | -19.7M +1.34% | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 19.3M +311.16% | -9.1M +1,148.56% | |
Total Nonoperating Income and Expense | 13.3M -18.21% | 16.2M +10.84% | 14.6M +213.73% | -12.9M +154.53% | |
Income before Taxes | -49.0M -150.10% | 97.9M +61.12% | 60.7M -16.99% | 73.2M -56.61% | |
Income Taxes | -10.5M -143.66% | 24.0M +74,915.63% | 32,000 -99.84% | 19.8M -52.63% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -38.5M -152.19% | 73.9M +21.67% | 60.7M +13.64% | 53.4M -57.92% | |
Net Income from Continuing Operations Applicable to Common | -49.0M -150.10% | 97.9M +61.12% | 60.7M -16.99% | 73.2M -56.61% | |
Basic EPS and Net Income | -0.68 -150.75% | 1.34 +18.58% | 1.13 +11.88% | 1.01 -58.09% | |
Diluted EPS and Net Income | -0.68 -151.52% | 1.32 +26.92% | 1.04 +6.12% | 0.98 -58.47% | |
Basic Weighted Average Shares | 56.5M +2.45% | 55.1M +2.67% | 53.7M +1.07% | 53.1M +0.92% | |
Diluted Weighted Average Shares | 56.5M +0.88% | 56.0M -9.28% | 61.7M +13.47% | 54.4M +1.24% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 128.4M +85.27% | 69.3M -25.55% | 93.1M -54.23% | 203.4M -29.52% | |
Short-Term Investments | 164.5M -53.68% | 355.2M -3.53% | 368.2M +170.26% | 136.2M +1.76% | |
Cash and Cash Equivalents and Short-Term Investments | 293.0M -30.99% | 424.5M -7.98% | 461.3M +35.81% | 339.7M -19.61% | |
Total Current Assets | 644.2M -6.11% | 686.1M -6.55% | 734.2M +22.04% | 601.6M -4.57% | |
Accumulated Depreciation | 18.3M +2.36% | 17.8M +36.74% | 13.0M -20.69% | 16.5M -3.44% | |
Property and Plant and Equipment and Net | 10.5M -8.78% | 11.5M -23.91% | 15.2M -10.51% | 17.0M -55.17% | |
Total Long-Term Assets | 63.8M +102.35% | 31.5M -20.80% | 39.8M -19.15% | 49.2M +13.83% | |
Total Assets | 1.5B +6.18% | 1.4B -19.64% | 1.7B +0.79% | 1.7B +12.30% | |
Income Taxes Payable | 0 -100.00% | 5.0M -90.04% | 49.8M -41.64% | 85.4M +142.38% | |
Total Short-Term Debt | 0 N/A | 0 -100.00% | 402.0M N/A | N/A N/A | |
Total Current Liabilities | 338.2M +15.65% | 292.4M -57.50% | 688.0M +118.14% | 315.4M +28.67% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 379.3M +4.84% | |
Total Long-Term Liabilities | 22.2M +192.00% | 7.6M -12.56% | 8.7M -46.94% | 16.4M -61.72% | |
Total Liabilities | 390.9M +17.63% | 332.3M -59.29% | 816.3M -6.53% | 873.3M +15.02% | |
Retained Earnings | 517.9M -6.93% | 556.4M +15.62% | 481.2M +26.67% | 379.9M +16.36% | |
Total Stockholders Equity | 1.1B +2.51% | 1.0B +16.87% | 886.2M +8.62% | 815.9M +9.53% | |
Total Shares Outstanding | 57.5M +3.08% | 55.7M +4.67% | 53.3M +0.73% | 52.9M +0.64% | |
Cash Flow | |||||
Cash from Operating Activities | 47.3M -72.47% | 172.0M +47.19% | 116.8M -8.10% | 127.1M -8.14% | |
Capital Expenditures | 1.3M +84.55% | 725,000 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 4.1M +102.16% | -189.9M -12.37% | -216.7M +164.50% | -81.9M +136.07% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 9.1M -25.12% | 12.2M +216.38% | -10.5M -91.97% | -130.4M -3,764.51% | |
Financials Ratio | |||||
Gross Margin | 88.10% N/A | N/A N/A | 86.93% -0.14% | 87.05% -3.19% | |
Operating Margin | -9.94% N/A | N/A N/A | 6.91% -53.41% | 14.84% -55.54% | |
Return on Assets | -2.73% N/A | N/A N/A | 3.58% +6.99% | 3.35% -64.89% | |
Return on Equity | -3.68% N/A | N/A N/A | 7.13% +4.20% | 6.85% -63.86% | |
Revenue Growth | -5.33% N/A | N/A N/A | 15.09% +32.21% | 11.41% -64.89% | |
Current Ratio | 1.90 N/A | N/A N/A | 1.07 -44.06% | 1.91 -25.84% | |
Cash Ratio | 0.38 N/A | N/A N/A | 0.14 -79.01% | 0.65 -45.23% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.45 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.24 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow